Anouk Déruaz‐Luyet

1.2k total citations
52 papers, 765 citations indexed

About

Anouk Déruaz‐Luyet is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Oncology. According to data from OpenAlex, Anouk Déruaz‐Luyet has authored 52 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Anouk Déruaz‐Luyet's work include Diabetes Treatment and Management (29 papers), Chronic Disease Management Strategies (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Anouk Déruaz‐Luyet is often cited by papers focused on Diabetes Treatment and Management (29 papers), Chronic Disease Management Strategies (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Anouk Déruaz‐Luyet collaborates with scholars based in United States, Germany and Switzerland. Anouk Déruaz‐Luyet's co-authors include Kimberly G. Brodovicz, Gregory A. Nichols, Sebastian Schneeweiß, Elisabetta Patorno, Lilli Herzig, Alexandra N’Goran, Mehdi Najafzadeh, Dagmar M. Haller, Lily G. Bessette and Ajinkya Pawar and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Anouk Déruaz‐Luyet

51 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anouk Déruaz‐Luyet United States	16	424	224	169	157	116	52	765
Fernando Álvarez Guisasola Spain	17	688 1.6×	213 1.0×	168 1.0×	206 1.3×	77 0.7×	64	1.2k
Rahul Aggarwal United States	16	163 0.4×	136 0.6×	102 0.6×	177 1.1×	102 0.9×	57	925
Kristen M. Tecson United States	15	239 0.6×	133 0.6×	128 0.8×	253 1.6×	62 0.5×	76	1.0k
Stéphane Roze United States	21	1.1k 2.7×	242 1.1×	121 0.7×	373 2.4×	124 1.1×	73	1.7k
Chih‐Cheng Hsu Taiwan	16	181 0.4×	163 0.7×	77 0.5×	107 0.7×	51 0.4×	56	801
Ji Lin United States	9	395 0.9×	174 0.8×	91 0.5×	102 0.6×	76 0.7×	13	778
Eduard Hermosilla Spain	7	213 0.5×	152 0.7×	77 0.5×	175 1.1×	42 0.4×	8	742
Izza Shahid United States	14	132 0.3×	130 0.6×	71 0.4×	81 0.5×	35 0.3×	63	826
Sayan Cheepudomwit Thailand	6	366 0.9×	209 0.9×	68 0.4×	82 0.5×	33 0.3×	13	722
Sarah J. Schrauben United States	17	184 0.4×	104 0.5×	59 0.3×	72 0.5×	178 1.5×	41	931

Countries citing papers authored by Anouk Déruaz‐Luyet

Since Specialization

Citations

This map shows the geographic impact of Anouk Déruaz‐Luyet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anouk Déruaz‐Luyet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anouk Déruaz‐Luyet more than expected).

Fields of papers citing papers by Anouk Déruaz‐Luyet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anouk Déruaz‐Luyet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anouk Déruaz‐Luyet. The network helps show where Anouk Déruaz‐Luyet may publish in the future.

Co-authorship network of co-authors of Anouk Déruaz‐Luyet

This figure shows the co-authorship network connecting the top 25 collaborators of Anouk Déruaz‐Luyet. A scholar is included among the top collaborators of Anouk Déruaz‐Luyet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anouk Déruaz‐Luyet. Anouk Déruaz‐Luyet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Jashin J., et al.. (2024). Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases. JAAD International. 15. 192–194. 1 indexed citations

Feldman, Steven R., et al.. (2024). Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databases. JAAD International. 15. 78–83. 1 indexed citations

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2024). Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia. 67(7). 1328–1342. 8 indexed citations

Tesfaye, Helen, Sebastian Schneeweiß, Deborah J. Wexler, et al.. (2024). Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovascular Diabetology. 23(1). 57–57. 14 indexed citations

Kim, Dae Jung, Wayne Huey‐Herng Sheu, Wook‐Jin Chung, et al.. (2023). Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of Diabetes Investigation. 14(3). 417–428. 6 indexed citations

Bergamasco, Aurore, et al.. (2022). Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review. Current Heart Failure Reports. 19(3). 146–156. 10 indexed citations

Desai, Rishi, Robert J. Glynn, Brendan M. Everett, et al.. (2022). Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care. American Heart Journal. 254. 203–215. 12 indexed citations

Sheu, Wayne Huey‐Herng, Yutaka Seino, Daisuke Yabe, et al.. (2021). HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY. Journal of the American College of Cardiology. 77(18). 1470–1470. 1 indexed citations

Kim, Dae Jung, Wayne H.-H. Sheu, Wook‐Jin Chung, et al.. (2021). CARDIOVASCULAR EFFECTIVENESS OF EMPAGLIFLOZIN COMPARED TO DPP4I IN ROUTINE CARE IN EAST ASIA: RESULTS FROM THE EMPRISE STUDY. Journal of the American College of Cardiology. 77(18). 542–542. 1 indexed citations

10.

Nichols, Gregory A., Anouk Déruaz‐Luyet, Kimberly G. Brodovicz, et al.. (2020). Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. BMC Nephrology. 21(1). 167–167. 29 indexed citations

11.

Najafzadeh, Mehdi, Ajinkya Pawar, Sebastian Schneeweiß, et al.. (2019). Abstract 13655: Healthcare Resource Utilization Among Empagliflozin Initiators With and Without Cardiovascular Disease versus DPP4i in a Commercially-Insured Routine Care Population: An Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study. Circulation. 2 indexed citations

12.

Patorno, Elisabetta, Ajinkya Pawar, Jessica M. Franklin, et al.. (2019). Abstract 11928: Cardiovascular Effectiveness of Empagliflozin Compared to DPP4 Inhibitors and to GLP1 Receptor Agonists: Interim Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study. Circulation. 1 indexed citations

13.

Najafzadeh, Mehdi, Ajinkya Pawar, Anouk Déruaz‐Luyet, et al.. (2019). PDB128 REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY. Value in Health. 22. S161–S161. 4 indexed citations

14.

Pawar, Ajinkya, Elisabetta Patorno, Anouk Déruaz‐Luyet, et al.. (2019). PDB126 COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN IN REAL-WORLD PATIENTS AUGMENTING METFORMIN MONOTHERAPY WITH EMPAGLIFLOZIN FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY. Value in Health. 22. S161–S161. 2 indexed citations

15.

Herzig, Lilli, et al.. (2018). Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance System (Sentinella). BMJ Open. 8(3). e019616–e019616. 42 indexed citations

16.

Miret, Montserrat, Erzsébet Horváth–Puhó, Anouk Déruaz‐Luyet, Henrik Toft Sørensen, & Véra Ehrenstein. (2017). Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study. PLoS ONE. 12(8). e0181564–e0181564. 12 indexed citations

17.

Nichols, Gregory A., Kimberly G. Brodovicz, Teresa M. Kimes, Anouk Déruaz‐Luyet, & Dorothee B. Bartels. (2017). Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes. Journal of Diabetes and its Complications. 31(11). 1587–1591. 33 indexed citations

18.

Déruaz‐Luyet, Anouk, Alexandra N’Goran, Jérôme Pasquier, et al.. (2017). Determinants associated with deprivation in multimorbid patients in primary care—A cross-sectional study in Switzerland. PLoS ONE. 12(7). e0181534–e0181534. 10 indexed citations

19.

N’Goran, Alexandra, J. Blaser, Anouk Déruaz‐Luyet, et al.. (2016). From chronic conditions to relevance in multimorbidity: a four-step study in family medicine. Family Practice. 33(4). 439–444. 28 indexed citations

20.

Déruaz‐Luyet, Anouk, Alexandra N’Goran, Ryan Tandjung, et al.. (2015). Multimorbidity in primary care: protocol of a national cross-sectional study in Switzerland. BMJ Open. 5(10). e009165–e009165. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact